Additional information
White Powder
1514933-19-7
ACI-015712
135.3-136.8°C
C33H28N6O8
636.61
Ambient
2-8°C
Hypertension
Pharmaceutical Impurity Standards
5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1[[2’-[(hydroxyamino)[(1H-imidazol-1-ylcarbonyl)imino]methyl][1,1’-biphenyl]-4-yl]methyl]-1H-benimidazole-7-carboxylate
5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1[[2’-[(hydroxyamino)[(1H-imidazol-1-ylcarbonyl)imino]methyl][1,1’-biphenyl]-4-yl]methyl]-1H-benimidazole-7-carboxylate.
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2?-[(hydroxyamino)[(1H-imidazol-1-ylcarbonyl)imino]methyl][1,1?-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester





![N-METHYL ENZALUTAMIDE (25 mg) (4-{3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl}-2-fluoro-N,N-dimethylbenzamide)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)